Drug Duo Enhances Myeloma Outcomes

Primary results of phase 3 AURIGA study indicated that dual maintenance therapy after transplant led to improved outcomes.
Medscape Medical News

source https://www.medscape.com/viewarticle/drug-duo-enhances-myeloma-outcomes-2025a10001w2?src=rss